Literature DB >> 27033256

Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Per Hydbring1,2, Marcos Malumbres3, Piotr Sicinski1,2.   

Abstract

The roles of cyclins and their catalytic partners, the cyclin-dependent kinases (CDKs), as core components of the machinery that drives cell cycle progression are well established. Increasing evidence indicates that mammalian cyclins and CDKs also carry out important functions in other cellular processes, such as transcription, DNA damage repair, control of cell death, differentiation, the immune response and metabolism. Some of these non-canonical functions are performed by cyclins or CDKs, independently of their respective cell cycle partners, suggesting that there was a substantial divergence in the functions of these proteins during evolution.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27033256      PMCID: PMC4841706          DOI: 10.1038/nrm.2016.27

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  172 in total

1.  Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner.

Authors:  Agnès I Lukaszewicz; David J Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 2.  The history and future of targeting cyclin-dependent kinases in cancer therapy.

Authors:  Uzma Asghar; Agnieszka K Witkiewicz; Nicholas C Turner; Erik S Knudsen
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694

3.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.

Authors:  Syuzo Kaneko; Gang Li; Jinsook Son; Chong-Feng Xu; Raphael Margueron; Thomas A Neubert; Danny Reinberg
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

4.  Cdk1 targets Srs2 to complete synthesis-dependent strand annealing and to promote recombinational repair.

Authors:  Marco Saponaro; Devon Callahan; Xiuzhong Zheng; Lumir Krejci; James E Haber; Hannah L Klein; Giordano Liberi
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

5.  Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis.

Authors:  L Gan; P Liu; H Lu; S Chen; J Yang; J B McCarthy; K E Knudsen; H Huang
Journal:  Cell Death Differ       Date:  2009-07-03       Impact factor: 15.828

6.  Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Oncogene       Date:  1998-08-27       Impact factor: 9.867

7.  Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.

Authors:  J Adnane; Z Shao; P D Robbins
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

Review 8.  Cyclin-dependent kinases.

Authors:  Marcos Malumbres
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1.

Authors:  Grzegorz Ira; Achille Pellicioli; Alitukiriza Balijja; Xuan Wang; Simona Fiorani; Walter Carotenuto; Giordano Liberi; Debra Bressan; Lihong Wan; Nancy M Hollingsworth; James E Haber; Marco Foiani
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

10.  Chromatin relaxation-mediated induction of p19INK4d increases the ability of cells to repair damaged DNA.

Authors:  María F Ogara; Pablo F Sirkin; Abel L Carcagno; Mariela C Marazita; Silvina V Sonzogni; Julieta M Ceruti; Eduardo T Cánepa
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

View more
  138 in total

Review 1.  CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought.

Authors:  Mary E Klein; Marta Kovatcheva; Lara E Davis; William D Tap; Andrew Koff
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

2.  Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.

Authors:  Xiao-Yan Jiang; Xiao-Song Zhu; Hong-Ya Xu; Zhong-Xi Zhao; Si-Ying Li; Shan-Zhong Li; Jian-Hua Cai; Ji-Min Cao
Journal:  Acta Pharmacol Sin       Date:  2017-03-27       Impact factor: 6.150

3.  Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1-Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression.

Authors:  Michael J Thwaites; Matthew J Cecchini; Daniel T Passos; Ian Welch; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2017-01-04       Impact factor: 4.272

Review 4.  Role of cyclins and cyclin-dependent kinases in pluripotent stem cells and their potential as a therapeutic target.

Authors:  Siwanon Jirawatnotai; Stephen Dalton; Methichit Wattanapanitch
Journal:  Semin Cell Dev Biol       Date:  2020-05-14       Impact factor: 7.727

5.  Loss of Cyclin-dependent Kinase 2 in the Pancreas Links Primary β-Cell Dysfunction to Progressive Depletion of β-Cell Mass and Diabetes.

Authors:  So Yoon Kim; Ji-Hyeon Lee; Matthew J Merrins; Oksana Gavrilova; Xavier Bisteau; Philipp Kaldis; Leslie S Satin; Sushil G Rane
Journal:  J Biol Chem       Date:  2017-01-18       Impact factor: 5.157

6.  Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration.

Authors:  Tamer M A Mohamed; Yen-Sin Ang; Ethan Radzinsky; Ping Zhou; Yu Huang; Arye Elfenbein; Amy Foley; Sergey Magnitsky; Deepak Srivastava
Journal:  Cell       Date:  2018-03-01       Impact factor: 41.582

7.  Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer.

Authors:  Yuchen Guo; Monica Gabola; Rossano Lattanzio; Conception Paul; Valérie Pinet; Ruizhi Tang; Hulya Turali; Julie Bremond; Ciro Longobardi; Chloé Maurizy; Quentin Da Costa; Pascal Finetti; Florence Boissière-Michot; Benjamin Rivière; Céline Lemmers; Séverine Garnier; François Bertucci; Inti Zlobec; Karim Chebli; Jamal Tazi; Rania Azar; Jean-Marie Blanchard; Peter Sicinski; Emilie Mamessier; Bénédicte Lemmers; Michael Hahne
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

Review 8.  Cell cycle proteins as promising targets in cancer therapy.

Authors:  Tobias Otto; Piotr Sicinski
Journal:  Nat Rev Cancer       Date:  2017-01-27       Impact factor: 60.716

Review 9.  Insulin regulation of gluconeogenesis.

Authors:  Maximilian Hatting; Clint D J Tavares; Kfir Sharabi; Amy K Rines; Pere Puigserver
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.